Humanized monoclonal anti-GD2 antibody (St Jude Children's Research Hospital)
- Generic Name
- Humanized monoclonal anti-GD2 antibody (St Jude Children's Research Hospital)
Therapy for Children With Advanced Stage Neuroblastoma
Phase 2
Active, not recruiting
- Conditions
- Neuroblastoma
- Interventions
- Procedure: peripheral blood stem cell harvestProcedure: surgical resectionBiological: peripheral blood stem cell transplantationBiological: natural killer cell infusionRadiation: radiation therapyDevice: CliniMACS
- First Posted Date
- 2013-05-20
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 153
- Registration Number
- NCT01857934
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath